NCT00578266 - Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 16, 2016

Study Completion Date

August 16, 2016

Conditions

Anemia, Aplastic

Interventions

DRUG

Cyclophosphamide,Campath IH and TBI

"DAY 5 TREATMENT~* 6 5 CYTOXAN 50 mg/kg WITH MESNA~* 5 CYTOXAN 50 mg/kg WITH MESNA;~* 4 CYTOXAN 50 mg/kgWITH MESNA; CAMPATH 3-10 mg~* 3 CYTOXAN 50 mg/kg WITH MESNA; CAMPATH;~* 2 TBI; CAMPATH; TACROLIMUS~* 1 TBI (second fraction); CAMPATH (am) 0 STEM CELL INFUSION (pm)"

Trial Locations (1)

55905

Mayo Clinic, Rochester